These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 17538891

  • 1. C1 inhibitor treatment improves host defense in pneumococcal meningitis in rats and mice.
    Zwijnenburg PJ, van der Poll T, Florquin S, Polfliet MM, van den Berg TK, Dijkstra CD, Roord JJ, Hack CE, van Furth AM.
    J Infect Dis; 2007 Jul 01; 196(1):115-23. PubMed ID: 17538891
    [Abstract] [Full Text] [Related]

  • 2. Mechanisms of complement activation and effects of C1-inhibitor on the meconium-induced inflammatory reaction in human cord blood.
    Salvesen B, Nielsen EW, Harboe M, Saugstad OD, Mollnes TE.
    Mol Immunol; 2009 Feb 01; 46(4):688-94. PubMed ID: 18950866
    [Abstract] [Full Text] [Related]

  • 3. Recombinant C1 inhibitor in brain ischemic injury.
    Gesuete R, Storini C, Fantin A, Stravalaci M, Zanier ER, Orsini F, Vietsch H, Mannesse ML, Ziere B, Gobbi M, De Simoni MG.
    Ann Neurol; 2009 Sep 01; 66(3):332-42. PubMed ID: 19798727
    [Abstract] [Full Text] [Related]

  • 4. Tumor necrosis factor alpha (TNF-alpha) levels in the brain and cerebrospinal fluid after meningitis induced by Streptococcus pneumoniae.
    Barichello T, dos Santos I, Savi GD, Florentino AF, Silvestre C, Comim CM, Feier G, Sachs D, Teixeira MM, Teixeira AL, Quevedo J.
    Neurosci Lett; 2009 Dec 31; 467(3):217-9. PubMed ID: 19835931
    [Abstract] [Full Text] [Related]

  • 5. A kinetic study of the cytokine/chemokines levels and disruption of blood-brain barrier in infant rats after pneumococcal meningitis.
    Barichello T, Pereira JS, Savi GD, Generoso JS, Cipriano AL, Silvestre C, Petronilho F, Dal-Pizzol F, Vilela MC, Teixeira AL.
    J Neuroimmunol; 2011 Apr 31; 233(1-2):12-7. PubMed ID: 21109308
    [Abstract] [Full Text] [Related]

  • 6. Experimental pneumococcal meningitis in mice: a model of intranasal infection.
    Zwijnenburg PJ, van der Poll T, Florquin S, van Deventer SJ, Roord JJ, van Furth AM.
    J Infect Dis; 2001 Apr 01; 183(7):1143-6. PubMed ID: 11237845
    [Abstract] [Full Text] [Related]

  • 7. Impact of bacteremia on the pathogenesis of experimental pneumococcal meningitis.
    Brandt CT, Holm D, Liptrot M, Ostergaard C, Lundgren JD, Frimodt-Møller N, Skovsted IC, Rowland IJ.
    J Infect Dis; 2008 Jan 15; 197(2):235-44. PubMed ID: 18173365
    [Abstract] [Full Text] [Related]

  • 8. Effects of C1 inhibitor on tissue damage in a porcine model of controlled hemorrhage.
    Dalle Lucca JJ, Li Y, Simovic M, Pusateri AE, Falabella M, Dubick MA, Tsokos GC.
    Shock; 2012 Jul 15; 38(1):82-91. PubMed ID: 22683724
    [Abstract] [Full Text] [Related]

  • 9. Effect of supraphysiologic levels of C1-inhibitor on the classical, lectin and alternative pathways of complement.
    Nielsen EW, Waage C, Fure H, Brekke OL, Sfyroera G, Lambris JD, Mollnes TE.
    Mol Immunol; 2007 Mar 15; 44(8):1819-26. PubMed ID: 17101176
    [Abstract] [Full Text] [Related]

  • 10. Protective role of NF-kappaB1 (p50) in experimental pneumococcal meningitis.
    Kastenbauer S, Koedel U, Weih F, Ziegler-Heitbrock L, Pfister HW.
    Eur J Pharmacol; 2004 Sep 13; 498(1-3):315-8. PubMed ID: 15364010
    [Abstract] [Full Text] [Related]

  • 11. Complement factor 1 inhibitor improves cardiopulmonary function in neonatal cardiopulmonary bypass.
    Baig K, Nassar R, Craig DM, Quick G, Jiang HX, Frank MM, Lodge AJ, Anderson PA, Jaggers J.
    Ann Thorac Surg; 2007 Apr 13; 83(4):1477-82; discussion 1483. PubMed ID: 17383361
    [Abstract] [Full Text] [Related]

  • 12. C1-Esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema.
    Caliezi C, Wuillemin WA, Zeerleder S, Redondo M, Eisele B, Hack CE.
    Pharmacol Rev; 2000 Mar 13; 52(1):91-112. PubMed ID: 10699156
    [Abstract] [Full Text] [Related]

  • 13. Differences in survival, brain damage, and cerebrospinal fluid cytokine kinetics due to meningitis caused by 3 different Streptococcus pneumoniae serotypes: evaluation in humans and in 2 experimental models.
    Østergaard C, Brandt C, Konradsen HB, Samuelsson S.
    J Infect Dis; 2004 Oct 01; 190(7):1212-20. PubMed ID: 15346330
    [Abstract] [Full Text] [Related]

  • 14. Plasma-derived human C1-esterase inhibitor does not prevent mechanical ventilation-induced pulmonary complement activation in a rat model of Streptococcus pneumoniae pneumonia.
    de Beer FM, Aslami H, Hoeksma J, van Mierlo G, Wouters D, Zeerleder S, Roelofs JJ, Juffermans NP, Schultz MJ, Lagrand WK.
    Cell Biochem Biophys; 2014 Nov 01; 70(2):795-803. PubMed ID: 24760631
    [Abstract] [Full Text] [Related]

  • 15. Interleukin-18 gene-deficient mice show enhanced defense and reduced inflammation during pneumococcal meningitis.
    Zwijnenburg PJ, van der Poll T, Florquin S, Akira S, Takeda K, Roord JJ, van Furth AM.
    J Neuroimmunol; 2003 May 01; 138(1-2):31-7. PubMed ID: 12742650
    [Abstract] [Full Text] [Related]

  • 16. Effect of C1 inhibitor on inflammatory and physiologic response patterns in primates suffering from lethal septic shock.
    Jansen PM, Eisele B, de Jong IW, Chang A, Delvos U, Taylor FB, Hack CE.
    J Immunol; 1998 Jan 01; 160(1):475-84. PubMed ID: 9552006
    [Abstract] [Full Text] [Related]

  • 17. An infant mouse model of brain damage in pneumococcal meningitis.
    Grandgirard D, Steiner O, Täuber MG, Leib SL.
    Acta Neuropathol; 2007 Dec 01; 114(6):609-17. PubMed ID: 17938941
    [Abstract] [Full Text] [Related]

  • 18. C1-inhibitor attenuates neurobehavioral deficits and reduces contusion volume after controlled cortical impact brain injury in mice.
    Longhi L, Perego C, Ortolano F, Zanier ER, Bianchi P, Stocchetti N, McIntosh TK, De Simoni MG.
    Crit Care Med; 2009 Feb 01; 37(2):659-65. PubMed ID: 19114897
    [Abstract] [Full Text] [Related]

  • 19. Complement deficiency states and associated infections.
    Skattum L, van Deuren M, van der Poll T, Truedsson L.
    Mol Immunol; 2011 Aug 01; 48(14):1643-55. PubMed ID: 21624663
    [Abstract] [Full Text] [Related]

  • 20. The pro-inflammatory cytokine interferon-gamma is an important driver of neuropathology and behavioural sequelae in experimental pneumococcal meningitis.
    Too LK, Ball HJ, McGregor IS, Hunt NH.
    Brain Behav Immun; 2014 Aug 01; 40():252-68. PubMed ID: 24607660
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.